Skin manifestations associated with Glucagon-Like Peptide-1 (GLP-1) receptor agonist use for weight loss: A cross-sectional analysis. J Pak Assoc Dermatol [Internet]. 2026 Mar. 31 [cited 2026 Jul. 1];36(1):3-9. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/3221